Hangzhou Biotest Biotech Co.,Ltd. (SHSE: 688767)
Health Care · Biotechnology · CN
CN¥39.60
-1.49% today · -4.2% 1Y
Hangzhou Biotest Biotech Co.,Ltd. (SHSE: 688767) operates in the Biotechnology industry within the Health Care sector. The company is valued at $865.08M and employs 598 people.
Over the last twelve months the share price has lost 4.2%, trading between 30.40 and 50.98.
Tweenvest scores Hangzhou Biotest Biotech Co.,Ltd. across four factors: quality 67/100, value 29/100, growth 0/100, dividend 61/100. Its strongest factor is quality.
688767 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $865.08M
- Revenue (TTM)
- $67.63M
- P/E
- 256.57
- EPS
- 0.15
- Dividend yield
- 1.77%
- Beta (5Y)
- 0.66
- 52-week high
- CN¥50.98
- 52-week low
- CN¥30.40
- Avg volume (3M)
- —
- Shares outstanding
- 146.32M
- Employees
- 598
- Next earnings
- —
About Hangzhou Biotest Biotech Co.,Ltd.
Hangzhou Biotest Biotech Co., LTD. is an enterprise focused on the research, development, manufacturing, sales, and servicing of in vitro diagnostic (IVD) solutions. Operating both domestically within China and across international markets, the company provides a comprehensive range of medical testing products. Their offerings span crucial health areas including reproductive health, cancer detection, cardiovascular conditions, inflammatory markers, biochemical analysis, and various infectious diseases. This extensive portfolio also encompasses rapid diagnostic tests for COVID-19 (covering both antibody and antigen detection), as well as screening kits for drug use (utilizing urine, saliva, and hair samples) and assessing vitamin D levels. Beyond diagnostic kits and reagents, Hangzhou Biotest Biotech also supplies essential accompanying equipment, such as immunochromatography readers and fluorescence immunoassay quantitative analyzers. The company, established in 2008, is based in Hangzhou, China.
- ISIN
- CNE1000050H0
- Founded
- 2008
- Listed since
- Sep 8, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE | $878.73M | $10.52 | +2.14% |
| Lepu Biopharma Co., Ltd.SEHK: 2157 | $878.35M | HK$3.82 | -5.56% |
| Kuros Biosciences AGSWX: KURN | $878.10M | CHF18.78 | +2.34% |
| PeptiDream Inc.TSE: 4587 | $872.86M | ¥1,075.00 | +2.14% |
| Sana Biotechnology, Inc.NasdaqGS: SANA | $835.22M | $2.62 | -6.09% |
| Arbutus Biopharma CorporationNasdaqGS: ABUS | $834.92M | $4.15 | -1.66% |
| Oxford Biomedica plcLSE: OXB | $834.48M | £5.35 | +2.69% |
| CARsgen Therapeutics Holdings LimitedSEHK: 2171 | $833.26M | HK$11.63 | -6.59% |
Figures last refreshed Oct 11, 2026.